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Available online 16 May 2008Single-nucleotide polymorphism (SNP) arrays have become a popular technology for disease-association
studies, but they also have potential for studying the genetic differentiation of human populations.
Application of the Affymetrix GeneChip Human Mapping 500K Array Set to a population of 102 individuals
representing the major ethnic groups in the United States (African, Asian, European, and Hispanic) revealed
patterns of gene diversity and genetic distance that reﬂected population history. We analyzed allelic
frequencies at 388,654 autosomal SNP sites that showed some variation in our study population and 10% or
fewer missing values. Despite the small size (23–31 individuals) of each subpopulation, there were no ﬁxed
differences at any site between any two subpopulations. As expected from the African origin of modern
humans, greater gene diversity was seen in Africans than in either Asians or Europeans, and the genetic
distance between the Asian and the European populations was signiﬁcantly lower than that between either of
these two populations and Africans. Principal components analysis applied to a correlation matrix among
individuals was able to separate completely the major continental groups of humans (Africans, Asians, and
Europeans), while Hispanics overlapped all three of these groups. Genes containing two or moremarkers with
extraordinarily high genetic distance between subpopulations were identiﬁed as candidate genes for health
differences between subpopulations. The results show that, even with modest sample sizes, genome-wide
SNP genotyping technologies have great promise for capturing signatures of gene frequency difference
between human subpopulations, with applications in areas as diverse as forensics and the study of ethnic
health disparities.
© 2008 Elsevier Inc. All rights reserved.Keywords:
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Complex diseaseRecent years have seen an increasing interest in health disparities
among human subpopulations [1–3] and the possibility that genetic
differences among human populations may play some role in health
differences [4–6]. Substantial genetic evidence supports the hypoth-
esis thatmodernhumansoriginated inAfrica [7–9]. Populationswhose
ancestors emigrated out of Africa to Europe and Asia came to differ
from the African population in allelic frequencies as a result of both
population bottlenecks in emigration and subsequent genetic drift. As
a result, major geographic subdivisions of the human population are
known to differ from one another in allelic frequencies at numerous
loci, from allozymes [10] to Alu insertionpolymorphisms [11] to single-
nucleotide polymorphisms [12]. However, relatively few ﬁxed differ-
ences occur between major geographic subdivisions of humans; most
known differences involve allele frequency differences, not the
complete replacement of one allele by another. Moreover, if studied
on a ﬁne geographic scale, much of the gene frequency difference
between continents appears to be clinal [13].l rights reserved.The diseases for which studies have shown differences of incidence
between human subpopulations are typically complex diseases whose
etiology is thought to involve both environmental and, possibly,
genetic factors [14–19]. The genetic contribution to complex diseases is
thought to be polygenic and to involve small contributions from a
number of relatively common allelic variants, in sharp contrast to
Mendelian disease genes subject to a mutation-selection balance
[5,20]. Such common allelic variants might plausibly be among those
that differ in allelic frequency between major human subpopulations
because of either genetic drift or adaptation to local environmental
conditions. Furthermore, described differences between human
populations with respect to complex disease phenotypes typically
involve frequency differences, as would be expected if gene frequency
differences play a role.
Array technologies have become an important tool in assaying
humangenetic variation and in geneticdisease-association studies. Here
we applied the Affymetrix GeneChip HumanMapping 500KArray Set to
the SNP500 Cancer population, a population of 102 individuals repre-
sentingmajor U.S. ethnic groups [21]. The 500,000 SNPs assayed by this
system were chosen to provide markers evenly distributed along the
chromosomes andhaving relatively high genediversity (heterozygosity)
Table 1
Gene diversity at 388,654 autosomal SNP sites
Population Mean±SE Median (range)
African 0.27804±0.00026 0.28733 (0.00000–0.50000)
European 0.25281±0.00029a 0.26977b (0.00000–0.50000)
Asian 0.24535±0.00029a,c 0.28733b,d (0.00000–0.50000)
Hispanic 0.26874±0.00027a,c,e 0.28733b,d,f (0.00000–0.50000)
All 0.28112±0.00025 0.29066 (0.00976–0.50000)
aSigniﬁcantly different from African (two-tailed pb0.001; paired t test).
bSigniﬁcantly different from African (two-tailed pb0.001; Wilcoxon signed-rank test).
cSigniﬁcantly different from European (two-tailed pb0.001; paired t test).
dSigniﬁcantly different fromEuropean (two-tailed pb0.001;Wilcoxon signed-rank test).
eSigniﬁcantly different from Asian (two-tailed pb0.001; paired t test).
fSigniﬁcantly different from Asian (two-tailed pb0.001; Wilcoxon signed-rank test).
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HapMap project [22]. We ﬁrst analyzed the results for the expected
signatures of human population history. These included gene frequency
differences at these SNP sites between populations in our sample re-
presenting the major historic subdivisions of humans (African,
European, and Asian), as well as evidence of admixture, particularly in
the U.S. Hispanic populations. In looking for these signatures, we tested
both whether the SNP500 population shows evidence of population
history and whether the 500K Array Set can be used to discover aspects
of human population history. Next we searched for evidence of protein-
coding genes containing more markers with elevated interpopulation
gene frequency differences than expected by chance, on the expectation
that such genes may contribute to phenotypic differences between
populations, possibly including complex disease phenotypes.
Results
Gene diversity and genetic distance
We computed overall mean and median gene diversity in the
SNP500 Cancer population for 388,654 autosomal SNP loci assayed by
the Affymetrix GeneChip Human Mapping 500K Array Set. The mean
(0.281) and median (0.290) of the gene diversity in our study popu-
lation were quite high (Table 1), reﬂecting the manufacturer's choice
of high-diversity markers. Nonetheless, there were signiﬁcant dif-
ferences among subpopulations with respect to gene diversity, sup-
ported by both parametric and nonparametric tests (Table 1). The
African subpopulation showed the highest mean andmedian values of
gene diversity, both of which differed signiﬁcantly from those of otherTable 2
Genetic distance between populations at 388,654 autosomal SNP sites
Comparison Mean±SE Median (range)
African–European 0.03718±0.00008 0.02014 (0.00000–0.68377)
African–Asian 0.04223±0.00009a 0.02198b (0.00000–0.68377)
European–Asian 0.02404±0.00006a,c 0.01019b,d (0.00000–0.51099)
African–Hispanic 0.02559±0.00005a 0.01250b (0.00000–0.54437)
European–Hispanic 0.00978±0.00004e 0.00431f (0.00000–0.20600)
Asian–Hispanic 0.01878±0.00004g 0.01047h (0.00976–0.46839)
aSigniﬁcantly different from African–European distance (two-tailed pb0.001; paired
t test).
bSigniﬁcantly different from African–European distance (two-tailed pb0.001; Wilcoxon
signed-rank test).
cSigniﬁcantly different from African–Asian distance (two-tailed pb0.001; paired t test).
dSigniﬁcantly different from African–Asian distance (two-tailed pb0.001; Wilcoxon
signed-rank test).
eSigniﬁcantly different from African–Hispanic distance and from Asian–Hispanic
distance (two-tailed pb0.001 in each case; paired t tests).
fSigniﬁcantly different from African–Hispanic distance and from Asian–Hispanic
distance (two-tailed pb0.001 in each case; Wilcoxon signed-rank tests).
gSigniﬁcantly different from European–Asian distance (two-tailed pb0.001; paired t test).
hSigniﬁcantly different from European–Asian distance (two-tailed pb0.001; Wilcoxon
signed-rank test).subpopulations (Table 1). The Hispanic subpopulation interestingly
showed signiﬁcantly greater mean and median gene diversity than
either the European or the Asian subpopulation, but signiﬁcantly less
than the African subpopulation (Table 1).
The mean and median values of the genetic distance between the
African and the Asian subpopulations were signiﬁcantly greater than
those between the African and the European (Table 2). This difference
may reﬂect European admixture in the case of African Americans. The
Hispanic subpopulation showed the lowest mean and median genetic
distance with the European subpopulation, signiﬁcantly lower than
those between Hispanic and African or Hispanic and Asian (Table 2).
On the other hand, the Hispanic subpopulation showed signiﬁcantly
lower mean and median genetic distance with the African subpopula-
tion than did the European subpopulation (Table 2). Likewise, the
Hispanic population showed signiﬁcantly lower mean and median
genetic distance with the Asian subpopulation than did the European
subpopulation (Table 2).
Despite gene frequency differences between populations, none of
the 388,654 sites showed a ﬁxed difference between any two sub-
populations; that is, there was no case inwhich one allele was ﬁxed in
one subpopulation and another allele was ﬁxed in another subpopula-
tion. When gene diversities and genetic distances were calculated
only for the SNP sites with no missing values (N=133,826), the pat-
terns were similar to those seen in the larger data set (not shown).
Genetic correlations among individuals
We analyzed genetic correlations among individuals to determine
to what extent gene frequency information at these SNP sites could be
used to separate major continental groups of humans. There wereFig. 1. Plots of loadings on principal components (PCs) extracted from the matrix of
genetic correlations at 150,557 SNP sites in 79 individuals (excluding Hispanics). (A) PC2
vs PC1; (B) PC3 vs PC2.
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European subpopulations. When pairwise correlations were calcu-
lated among the 79 individuals in these three subpopulations, the
mean of 1017 within-subpopulation correlations (0.652±0.001 SE)
differed signiﬁcantly from the mean of 2064 between-population
correlations (0.570±0.001; pb0.001; randomization test).
We extracted principal components from the 79×79 matrix of
genetic correlation coefﬁcients between individuals in the African,
Asian, and European subpopulations. The ﬁrst principal component
(PC1) accounted for 60.3% of the variance in the matrix. Loadings on
PC1 were relatively high in members of the African subpopulation in
comparison to Asian and European subpopulations, although Africans
were not completely separated from the other subpopulations along
this axis (Fig. 1A). Thus PC1 seemed to reﬂect mainly patterns of gene
frequency originating in Africa. PC2, which accounted for 4.0% of the
variance, clearly contrasted Africans, on the one hand, and Asians and
Europeans, on the other hand (Fig. 1A). PC3, which accounted for 2.6%
of the variance, contrasted Asians with Europeans (Fig. 1B).
When loadings on PC2 and PC3 were plotted on the same set of axes,
the three major continental subpopulations (Africans, Asians, Europeans)
were completely separated from one another in two-dimensional space
(Fig. 1B). No other principal component beyond PC1, PC2, and PC3
accounted for more than 1% of the variance in the data. The majority of
Asians showed strongly negative loadings on PC3, strongly contrasting
with both Europeans and Africans on this axis (Fig. 1B). These individuals
(N=21) all had reported ancestry in East Asia. By contrast, three Asians
clustered much closer to Europeans on PC3 (Fig. 1B). The latter three had
reported ancestry in the Indian subcontinent.
When the Hispanic subpopulation was included, there were
133,826 sites with no missing values. Correlations among individualFig. 2. Plots of loadings on principal components extracted from the matrix of genetic
correlations at 133,826 SNP sites in 102 individuals (including Hispanics). (A) PC2 vs
PC1; (B) PC3 vs PC2.genotypic scores at these sites were estimated, and principal com-
ponents were extracted from the 102×102 correlation matrix. PC1,
accounting for 61.5% of the variance, again had high loadings on
Africans, although one Hispanic individual fell in the midst of the
Africans along this axis (Fig. 2A). Other Hispanics grouped with
Europeans and Asians along PC1 (Fig. 2A). PC2, accounting for 3.2% of
the variance, separated Africans from the other subpopulations,
except for one Hispanic individual (Fig. 2A). PC3, accounting for 2.0%
of the variance, separated one group of Asians from other Asians,
Europeans, and most Hispanics (Fig. 2B). No other principal compo-
nent accounted for as much as 1% of the variance.
Thus, when Hispanics were included in the analyses, the ﬁrst three
principal components took a form similar to those obtained when
Hispanics were excluded. The loadings on non-Hispanics of PC1, PC2,
and PC3 were very similar, in the data set including Hispanics (Fig. 2),
to the corresponding values for the data set excluding Hispanics
(Fig. 2). As a result, the three other subpopulations were still com-
pletely separated in two-dimensional space by PC2 and PC3 evenwhen
Hispanics were included (Fig. 2B). However, Hispanics themselves
could not be separated from the other subpopulations by principal
component analysis.
Genes with high divergence
Genetic distances at the 388,654 SNP sites for both the African-
Asian and the African-European comparisons showed strongly posi-
tively skewed distributions (Fig. 3). Skewness was 2.31 in the case of
the African–Asian distances and 2.41 in the case of African–European
distances. These high positive skewness values indicate a distribution
with a long right tail. We chose genes having two or more SNPs with
genetic distance N0.37 between African and Asian populations as
candidates for major allelic frequency differences between these two
populations (Table 3). Randomization tests applied to each chromo-
some indicated that the probability of twoormore such SNPs occurring
in a single gene by chance was less than 5×10-5. Likewise, we chose
genes having two or more SNPs with genetic distance N0.34 between
African and European populations as candidates for major allelic
frequency differences between these two populations (Table 4). Ran-
domization tests applied to each chromosome indicated that the
probability of two or more SNPs with genetic distances greater than
these cutoff values occurring in a single gene by chance was less than
5×10-5 in every case.
Almost all of the SNPs showing high interpopulation divergence in
these genes were in located in introns (Tables 3 and 4), reﬂecting the
choice of SNPs in the Affymetrix GeneChip Human Mapping 500K
Array Set. We searched dbSNP for reported nonsynonymous SNPs in
the exons of the same genes (Tables 3 and 4), since nonsynonymous
SNPs are most likely to have phenotypic effects. Certain of these
nonsynonymous SNPs showed interpopulation frequency differences,
paralleling those of the high-divergence SNPs (Tables 3 and 4). How-
ever, no population frequency data were available for the majority of
nonsynonymous SNPs in these genes.
Discussion
Application of theAffymetrixGeneChipHumanMapping500KArray
Set to a population of 102 individuals representing the major ethnic
groups in the United States (African, Asian, European, and Hispanic)
revealed patterns of gene diversity and genetic distance that reﬂected
population history. We analyzed allelic frequencies at 388,654 auto-
somal SNP sites that showed some variation in our studypopulation and
10% or fewer missing values. Despite the small size (23–31 individuals)
of each subpopulation, there were no ﬁxed differences at any site be-
tween any two subpopulations. Subpopulations of African, Asian, and
European origin showed gene frequency signatures consistent with the
history of the human continental populations. As expected from the
Fig. 3. Histograms illustrating frequency distributions of genetic distance at 388,654 SNP sites between (A) African and Asian and (B) African and European subpopulations.
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in Africans than in either Asians or Europeans, and the genetic distance
between the Asian and the European populations was signiﬁcantly
lower than that between either of these two populations and Africans.
Principal components were extracted from the correlation matrix
among individuals belonging to African, Asian, and European subpopu-
lations at 150,557 SNP siteswith nomissing values in any individual. The
ﬁrst principal component, accounting for about 60% of the variance,
appeared to reﬂect the African origin of all three subpopulations. On the
other hand, the second and third principal components set up contrasts
between the subpopulations. Although together accounting for 6.6% of
the variance, the second and third principal components perfectly
separated these three subpopulations. Thus, despite the absence ofﬁxed
differences, gene frequency data alone in samples of modest size pro-
vided sufﬁcient information to separate themajor continental groups of
humans. This was of interest in that the SNPs chosen for the Affymetrix
500KArray Setwere not chosen for their utility in distinguishing among
human subpopulations.
Because of complex population histories, human subpopulations
are not discrete categories from a genetic point of view [9,13,23].
While separating the major continental groups, the principal com-
ponent analysis also captured aspects of population history indicative
of gradation between continents. In the case of Asians, individuals
with ancestry in East Asia were much more strongly separated fromEuropeans than those with ancestry in the Indian subcontinent
(Fig. 1B). The latter clustered much closer to Europeans than did other
Asians, as is expected given the history of gene ﬂow across the
Eurasian landmass [13] and consistent with results reported for
microsatellite data [24].
WhenHispanicswere added to the analysis, theywere not separable
from the other subpopulations and in fact overlapped all three. While
Hispanics showed signiﬁcantly lower genetic distances from Europeans
than from Africans or Asians, Hispanics were signiﬁcantly closer to both
Africans and Asians than were Europeans. These results are consistent
with a predominant ancestry from Europe in the Hispanic population,
but with substantial African and Asian (Native American) contributions,
as has been hypothesized previously on the basis of both genetic and
historical data [25]. Thus, there was a clear signature in the data of the
admixed nature of the Hispanic subpopulation and the contribution of
all three major continental subpopulations. This ﬁnding is of interest in
that it suggests that a similar approach might be used to test for
admixture inother populationswhosehistory is not aswell documented
as that of U.S. Hispanics.
We identiﬁed certain protein-coding loci including two or more
SNPs with high African–Asian genetic distance and certain loci
including two or more SNPs with high African–European genetic
distance. These loci can be considered candidates for playing a role in
phenotypic differences between subpopulations, possibly including
Table 3
Genes with two or more SNPs showing signiﬁcantly (pb5×10−5) high African–Asian
genetic distance
Chromosome Locus (protein
function)
SNPs with high
genetic distancea
Known
nonsynonymous
SNPsa
1 LYST (lysosomal
trafﬁcking
regulator)
rs7522053 (I3);
rs7529320 (I3);
rs9970096 (I14);
rs57533575 (I28);
rs6667717 (I39)
rs6665568 (E20);
rs7541091 (E23);
rs2753327 (E35)
2 SEC15L2
(sec15-like 2)
rs11686713 (I3);
rs6546753 (I20)
rs2048173 (E1)
2 GLI2 (GLI–Kruppel
family member)
rs895552 (I2);
rs895553 (I2);
rs2871874 (I2);
rs11122834 (I2);
rs1466044 (I2)
rs1466042 (I2);
rs1107445 (I2)
rs13427953 (E5);
rs12618388 (E8);
rs3099537 (E8)
3 FHIT (fragile
histidine triad)
rs750793 (I8);
rs294451 (I8)
—
4 SLC30A9 (solute
carrier family 30,
zinc transporter,
member 9)
rs2581441 (I2);
rs10433709 (I8);
rs804191 (I11); rs11051
(E18, 3′UTR)
rs1047626 (E2);
rs1801962 (E12)
4 CCDC4
(coiled-coil domain-
containing 4)
rs6447132 (I3);
rs57664565 (I3)
—
4 SPATA5
(spermatogenesis-
associated 5)
rs307029 (I14);
rs307032 (I14)
rs28716389 (E16)
4 PALLD (paladin,
cytoskeletal-
associated protein)
rs4616716 (I3);
rs436442 (I16)
rs7655494 (E2);
rs7671781 (E2);
rs54293759 (E12)
5 CDH9 (cadherin 9,
type 2)
rs6871019 (I2);
rs10805793 (I2)
rs2288466 (E2);
rs2288467 (E2)
6 BAI3 (brain-speciﬁc
angiogenesis
inhibitor 3)
rs4706854 (I16);
rs7759645 (I16)
rs2183071 (E28)
8 XKR6 (Kell blood
group complex
subunit-related
family, member 6)
rs11773990 (I1);
rs10108618 (I1)
rs13255844 (E1)
9 IARS (isoleucine
tRNA synthase)
rs115757 (I19);
rs471478 (I30);
rs10761149 (I31)
rs5556155 (E27);
rs11547887 (E27);
rs17855985 (E27);
rs556155 (E32)
12 POLR3B (DNA-
directed RNA
polymerase III,
polypeptide B)
rs11112952 (I6);
rs2246353 (I12);
rs12305703 (I12)
rs17038460 (E18)
12 MPHOSPH9
(M-phase
phosphoprotein 9)
rs1716168 (I12); rs1716167
(I13)
rs1260318 (E18)
20 HM13 (minor
histocompatibility
13; signal peptide
peptidase)
rs6058022 (I1);
rs11906851 (I11);
rs6120719 (I11)
rs17855400 (E7);
rs1044419 (E8)
21 BACE2 (β-site APP-
cleaving enzyme 2)
rs766850 (I1); rs6517656
(I1); rs12329755 (I1)
—
aSNPs are designated by dbSNP ID. Abbreviations: I, intron; E, exon. Boldface indicates
nonsynonymous SNPs showing frequency differences between the two populations in
HapMap frequency data.
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these lists of candidate genes included many with known or probable
involvement in disease or disease-related processes, including certain
autoimmune diseases and cancers. For example, genes with high
African–Asian frequency differences included a number of genes
known or believed to be involved in disease-related processes. Some
of these genes are associated with Mendelian diseases. The SNPs
studied here are clearly not involved inMendelian disease, nor is there
evidence that the populations studied differ with respect to the
known diseases associated with these loci. Nonetheless, the fact thatmutation at a locus can cause Mendelian disease is evidence of the
functional importance of the locus.
The genes with high African–Asian frequency differences included
the following (disease-related functions and references in parenth-
eses): LYST (Chediak–Higashi syndrome [26]), GLI2 (brain and pitui-
tary developmental anomalies [27]), FHIT (tumor suppression [28]),
BAI3 (glioblastoma [29]), IARS (autoimmune polymyositis [30]),
HM13 (signal peptide cleaving for HLA-E presentation [31]), BACE
(Alzheimer disease [32]). In addition to GLI2, genes with high African–
European frequency differences included the following: HIVEP3 (HIV-
1 infection [33]), GLIS1 (psoriasis [34]), ICA1 (Type I diabetes [35]),
TNFSF8 (Hodgkin lymphoma [36]), APBA2 (Alzheimer disease [37]).
The LYST gene, which showed high genetic distances between
Africans and Asians, plays an important role in vesicle trafﬁcking and
thus in the immune system. A recessive mutation in this gene causes
Chediak–Higashi syndrome, a severe immune deﬁciency accompanied
by hypopigmentation [26]. Mutations at the orthologous mouse gene
can cause not only a similar immune disorder but also coat color
changes [38]. LYSTwas included in a recent survey of genes potentially
affecting human skin pigmentation genes and was reported to show a
signature of extended haplotype homozygosity in a Yoruban popula-
tion [39]. Interestingly, the LRBA gene, which showed genetic
distances between Africans and Europeans, encodes a protein that
shares sequence homology (including BEACH domains) with the
product of the LYST gene and likewise has a role in vesicle trafﬁcking
[40,41].
In recent years there has been a tendency to examine the human
genome for evidence of positive selection, including directional
selection leading to differences between subpopulations in allelic
frequency. On the other hand, several widely used methods of testing
for positive selection have been criticized for being overly non-
conservative statistically and based on ﬂawed statistical and biological
reasoning [42,43]. The rarity of ﬁxed differences between major
human groups is evidence that any differences in directional selection
between these groups must be either quite recent or relatively weak.
Whatever the truth about the prevalence of positive selection in
humans, there is evidence that purifying selection, which acts to
eliminate deleterious mutations, is by far more prevalent is human
coding regions than is positive selection [12,44–47]. A SNP site subject
to ongoing purifying selection will tend to show reduced genetic
distance between subpopulations [45]. Thus, whether allelic fre-
quency differences between subpopulations are due to selection or to
genetic drift, it can be concluded that purifying selection is generally
relaxed in the case of SNPs that show differences between subpopula-
tions [48].
Moreover, from the point of view of identifying the genetic basis of
health differences between human subpopulations, it may not be
particularly important whether drift or selection is responsible for a
given difference. In either case, the relaxation of purifying selection on
a given SNP site implies that the allelic differences at this site are not
likely to be deleterious. This in turn implies that major health dif-
ferences between human subpopulations are likely to involve not
deleterious genes per se but rather deleterious gene-by-environment
interactions. Several current hypotheses to account for ethnic dif-
ferences with respect to complex disease incidence are consistent
with this view. For example, the high level of type II diabetes in Native
Americans is believed to involve a gene-by-environment interaction
[49].
In conclusion, the present study shows that genotyping a large
number of SNPs with array technology provides substantial informa-
tion relevant to population history. Evenwith relatively small samples,
it is possible to assign individuals to the major geographic subpopula-
tions of humans (African, Asian, and European) on the basis of allelic
frequency patterns at highly polymorphic SNP sites. The latter ﬁnding
is not without interest for forensic applications of this technology.
In addition, the array technology can be used to identify genes with
Table 4
Genes with two or more SNPs showing signiﬁcantly high (pb5×10−5) African–European
genetic distance
Chromosome Locus (protein
function)
SNPs with high
genetic distancea
Known
nonsynonymous SNPsa
1 HIVEP3 (HIV-1
enhancer binding
protein 3)
rs2077354 (I1);
rs4526604 (I1);
rs710235 (I1);
rs4284254 (I1)
rs17363472 (E4);
rs2810566 (E4);
rs2181280 (E4);
rs2146315 (E4);
rs2291344 (E8);
rs2483689 (E8);
rs9439043 (E9)
rs11809423 (E9)
1 GLIS1 (GLIS family
zinc ﬁnger protein 1)
rs12062528 (I1);
rs12120383 (I2)
rs4307514 (E3)
2 MAP4K3 (mitogen-
activated protein
kinase kinase kinase
kinase 3)
rs6721049 (I1);
rs7596222 (I1)
rs13005084 (E1)
2 GLI2 (GLI–Kruppel
family member)
rs895552 (I2);
rs895553 (I2);
rs2871874 (I2);
rs11122834 (I2);
rs1466044 (I2);
rs1107445 (I2);
rs2311803 (I3)
rs13427953 (E5);
rs12618388 (E8);
rs3099537 (E8)
3 ULK4 (unk-51-like
kinase 4)
rs9864051 (I19);
rs9814300 (I8)
rs1052501 (E9);
rs3774372 (E10);
rs17063572 (E11);
rs4973986 (E12);
rs17215589 (E13);
rs6769117 (E29);
rs12488691 (E29)
4 ARHGAP10 (Rho
GTPase-activating
protein 10)
rs6535556 (I1);
rs6822971 (I1);
rs11729081 (I1);
rs17614025 (I10);
rs3990920 (I1);
rs1194409 (I13)
rs2276832 (E21)
4 LRBA (LPS-responsive
vesicle trafﬁcking,
BEACH and anchor
containing)
rs11099780 (I2);
rs2407548 (I2);
rs1201202 (I5);
rs7690977 (I22);
rs57665654 (I34);
rs1993109 (I35)
rs1782360 (E23);
rs13151295 (E24);
rs13151294 (E24);
rs17027133 (E30);
rs3749574 (E55);
rs2290846 (E57)
5 SEPT8 (septin 8) rs402959 (I1);
rs30527 (I1)
—
7 ICA1 (islet cell
autoantigen 1)
rs6977682 (I3);
rs1861032 (I4)
rs17847180 (E7)
8 SLC20A2 (solute
carrier family 20,
phosphate
transporter,
member 2)
rs7832529 (I5);
rs3888124 (I10)
—
8 ST18 (suppressor of
tumorigenicity 18,
carcinoma, zinc
ﬁnger protein)
rs12674582 (I2);
rs7459810 (I2);
rs7388668 (I2)
rs2303460 (E28)
8 XKR4 (Kell blood
group complex
subunit-related
family, member 4)
rs7844897 (I1);
rs16921658 (I1);
rs13439780 (I2)
—
9 ZNF782 (zinc ﬁnger
protein 782)
rs10124033 (I3);
rs7859940 (I5);
rs12236125 (I5)
rs4645656 (E6);
rs7870376 (E6)
9 TNFSF8 (tumor
necrosis factor ligand
superfamily,
member 8)
rs3181360 (I1);
rs3181362 (I3)
—
11 GRM5 (glutamate
receptor,
metabotropic 5)
rs10741500 (I2);
rs4488199 (I3);
rs992259 (I3)
—
14 GPHN (gephyrin) rs7156737 (I1);
rs8007677 (I2);
rs8022328 (I3);
rs723432 (I5);
rs8013401 (I8);
rs10142059 (I8);
—
Table 4 (continued)
Chromosome Locus (protein
function)
SNPs with high
genetic distancea
Known
nonsynonymous SNPsa
rs8003929 (I10);
rs10138850 (I16);
rs2281676 (I20)
15 APBA2 (amyloid β A4
precursor protein-
binding family A,
member 2)
rs4424881 (I1);
rs6495913 (I2)
rs8040932 (E3);
rs1046394 (E11);
rs4581676 (E11)
15 BRUNOL6
(bruno-like 6)
rs2959925 (I2);
rs1291497 (I3);
rs4777498 (E13, 3′
UTR)
rs17855555 (E1);
rs17852852 (E12)
16 ARHGAP17 (Rho
GTPase activating
protein 17)
rs8045868 (I10);
rs8045281 (I10)
rs28365822 (E19)
17 PCTP
(phosphatidylcholine
transfer protein)
rs2960070 (I1);
rs2960067 (I2)
rs12941739 (E1)
20 CDH26
(cadherin-like 26)
rs187751 (I5);
rs168982 (I5);
rs6128739 (E6);
rs6128740 (E6)
21 USP25 (ubiquitin-
speciﬁc peptidase 25)
rs2823504 (I17);
rs2823507 (I18)
rs2279797 (E18)
aSNPs are designated by dbSNP ID. Abbreviations: I, intron; E, exon. Boldface indicates
nonsynonymous SNPs showing frequency differences between the two populations in
HapMap frequency data.
14 GPHN (gephyrin)
6 A.L. Hughes et al. / Genomics 92 (2008) 1–8unusually high frequency differences among subpopulations, some of
which may contributed to phenotypic differences between racial and
ethnic groups, including health differences. The substantially more
extensive samples expected to be available in the near future will
further enhance the usefulness of array technology in addressing a
variety of basic and applied questions in human population genetics.
Materials and methods
Study population and genotyping
Genotype data were obtained for each of 102 unique anonymized individuals of
diverse geographic origin (the SNP500 Cancer population [21]). Each individual was
assigned to one of four subpopulations, on the basis of self-described ethnic group
afﬁliation. The four subpopulations were chosen to represent four major U.S. ethnic
groups: 24 African/African-American (here designated “African”), 31 Caucasian (here
designated “European), 24 Asian, and 23 Hispanic [21]. This panel of anonymized
samples, obtained from Coriell Cell Repositories (Coriell Institute for Medical Research,
Camden, NJ, USA), has been widely used as a resource for SNP and assay information
[21]. None of the individuals are related, and previous analyses of SNP data showed
differentiation among African, European, and Asian subpopulations consistent with
known human population history [12].
Genotype data were obtained using the Affymetrix GeneChip Human Mapping 500K
Array Set (http://www.affymetrix.com/products/arrays/speciﬁc/500k.affx), which uses
two different arrays to type, respectively, ~262,000 and ~238,000 SNPs. Of the SNPs
assayed, 63.4% are neither in introns nor inmRNA of predicted genes, 35.1% are in introns,
0.8% are in exons, 0.6% are in 3′UTRs, and 0.1% are in 5′UTRs. The software supplied by the
manufacturerwas used to determine SNP calls. For purpose of analyses, we excluded SNPs
on the X chromosome (N=4826), all SNPs for which fewer than 94 (90%) of the 102
individuals had missing data (i.e., unresolved genotype calls, N=96,915), and all SNPs for
which no diversity was observed in the study population (N=4463). The resulting data set
included 388,654 autosomal SNPs.
For analyses comparing individuals, we also used data sets including only SNPs for
which there were no missing data for any individual. There were 133,826 such sites
when the whole study population was used and 150,557 such sites when the Hispanic
group was excluded.
Statistical methods
At each SNP site (locus), the gene diversity (“heterozygosity”) was estimated by 1 -;
∑xi2, where xi is the frequency of the ith allelic variant at the site (Ref. [50], p. 177). For a
given biallelic SNP locus, the genetic distance (allelic frequency divergence) between
each pair of subpopulations was computed using the formula
d ¼ 1 x1y1ð Þ1=2þ x2y2ð Þ1=2
h i
;
7A.L. Hughes et al. / Genomics 92 (2008) 1–8where x1 and y1 are the frequencies of the ﬁrst allele in each of the two subpopulations,
respectively, and x2 and y2 are the frequencies of the second allele in each of the two
subpopulations, respectively. The average of d over all loci is the average genetic
distance (DA) (Ref. [50], p. 216). Skewness was used as a measure of the symmetry of
distribution of d [51]; skewness is 0 in the case of a perfectly symmetrical distribution
and positive in the case of a distribution with an extended right “tail.”
Using the restricted data sets with no missing values, we computed pairwise
genetic correlation coefﬁcients between individuals by assigning genotypic values (+1
for the BB homozygote, 0 for the heterozygote, and -1 for the AA homozygote, where A
and B arbitrarily designate the two alleles at the locus). To test the hypothesis that
genetic correlation coefﬁcients within subpopulations differed from those between
populations, we used a randomization test because the correlation coefﬁcients are not
independent of one another. In this test, we created 1000 pseudo-data sets by sampling
(with replacement) from the observed correlation coefﬁcients. Each pseudo-data set
included the same number of within-subpopulation correlations and between-
population correlations as did the real data, and randomly sampled values were
randomly assigned to each of the two categories. Principal component analysis [52] was
applied to the correlation matrix to identify principal orthologous axes in the matrix of
correlation coefﬁcients among individuals.
To identify genes that showed highly divergent allelic frequencies between
populations, we identiﬁed genes having two or more SNPs in our data set with
signiﬁcantly higher minimum d than expected for two SNPs chosen at random from
SNPs in our data set. We applied a Monte Carlo procedure (randomization test) to
identify the signiﬁcance level for minimum d for a random pair of genes. For each
chromosome, we sampled at random (with replacement) 200,000 pairs of SNPs and we
computed the minimum d for each pair. Because chromosomes differed with respect to
both the number of SNPs and the distribution of d, we applied the Monte Carlo
procedure separately to each chromosome; but then, for a conservative test, we used for
each chromosome a cutoff based on the upper tail of minimum d values observed in
randomizations for any of the chromosomes. In the case of d between African and
European populations, a minimum of d=0.34 for two or more SNPs in a gene provided a
two-tailed signiﬁcance level of 5×10-5 or better for any one of the chromosomes.
Likewise, in the case of d between African and Asian populations, a minimum of d=0.37
for two or more SNPs in a gene provided a two-tailed signiﬁcance level of 5×10-5 or
better for any one of the chromosomes. Each of these cutoff values corresponded to
approximately the top 0.1% of d values between the two populations compared across
all chromosomes. All statistical analyses were conducted using the Minitab statistical
package, release 13 (http://www.minitab.com/).
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